Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 536.83M P/E - EPS this Y 25.00% Ern Qtrly Grth -
Income -26.54M Forward P/E -28.69 EPS next Y -5.70% 50D Avg Chg -28.00%
Sales 8k PEG - EPS past 5Y - 200D Avg Chg -13.00%
Dividend N/A Price/Book 184.46 EPS next 5Y - 52W High Chg -50.00%
Recommedations 2.00 Quick Ratio 5.80 Shares Outstanding 34.54M 52W Low Chg 286.00%
Insider Own 17.85% ROA -44.61% Shares Float 27.96M Beta -
Inst Own 20.57% ROE -88.57% Shares Shorted/Prior 1.13M/1.24M Price 20.66
Gross Margin 100.00% Profit Margin - Avg. Volume 46,503 Target Price 19.20
Oper. Margin -341,437.50% Earnings Date - Volume 24,467 Change 0.78%
About Genelux Corporation

Genelux Corporation, a clinical-stage biopharmaceutical company, focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive and/or difficult-to-treat solid tumor types. Its lead product candidate is Olvi-Vec, a proprietary modified strain of the vaccinia virus for the treatment of ovarian cancer and non-small cell lung cancer. The company is also developing V2ACT Immunotherapy for treating pancreatic cancer. Genelux Corporation has a licensing agreement with ELIAS Animal Health, LLC for V-VET1, a clinical stage animal health product candidate. The company was incorporated in 2001 and is headquartered in Westlake Village, California.

Genelux Corporation News
11/15/24 These 2 “Strong Buy” Penny Stocks Are Set to Triple (or more), Say Analysts
11/14/24 Genelux Corporation Reports Third Quarter 2024 Financial Results and Provides General Business Updates
11/06/24 Genelux Corporation to Participate in Fireside Chat at the Guggenheim Inaugural Healthcare Innovation Conference
10/31/24 Individual investors who hold 56% of Genelux Corporation (NASDAQ:GNLX) gained 34%, institutions profited as well
10/25/24 Highbridge Capital Management LLC Acquires Significant Stake in Genelux Corp
10/23/24 Genelux doses first subject in Phase II trial of NSCLC treatment
10/22/24 Genelux Corporation Announces First Patient Dosed in Phase 2 Trial Evaluating Systemic Therapy with Olvi-Vec in Non-Small Cell Lung Cancer
10/09/24 Genelux Corporation to Participate in the 2024 Maxim Healthcare Virtual Summit
09/03/24 Genelux Corporation to Present at the H.C. Wainwright Global Investment Conference
08/17/24 Is Genelux (NASDAQ:GNLX) In A Good Position To Invest In Growth?
08/14/24 Genelux Corporation Reports Second Quarter 2024 Financial Results and Provides General Business Updates
08/12/24 Genelux Corporation (GNLX): A Strong Buy According to Hedge Funds
07/30/24 Genelux Corporation to Participate in Fireside Chat at BTIG’s Virtual Biotechnology Conference 2024
05/24/24 Genelux Prices $27.5 Million Securities Offering at $4 a Share; Shares Drop
05/24/24 Genelux Corporation Announces Pricing of Approximately $27.5 Million Underwritten Offering of Common Stock and Accompanying Warrants
05/23/24 Genelux Corporation Announces Proposed Public Offering of Common Stock and Warrants
05/09/24 Genelux Corporation Reports First Quarter 2024 Financial Results and Provides General Business Updates
05/05/24 Genelux Corporation's (NASDAQ:GNLX) market cap rose US$11m last week; individual investors who hold 54% profited and so did insiders
04/26/24 Down -48.37% in 4 Weeks, Here's Why Genelux Corporation (GNLX) Looks Ripe for a Turnaround
04/23/24 Down -45.44% in 4 Weeks, Here's Why Genelux Corporation (GNLX) Looks Ripe for a Turnaround
GNLX Chatroom

User Image Randy__ Posted - 1 day ago

$GNLX yes. Picked up 4500 shares at that 2.41 drop.

User Image Randy__ Posted - 1 day ago

$GNLX Wow!!

User Image Kupper Posted - 2 days ago

$GNLX I would love to find the people that are manipulating this down and beat the shit out of them. Assholes.

User Image Kupper Posted - 2 days ago

$GNLX

User Image Randy__ Posted - 2 days ago

$GNLX Just picked up5k shares here. Personal for me. Lost 2 family member in the past 6 months to cancer!

User Image Kupper Posted - 6 days ago

$GNLX what is going on here and causing it to go down again?

User Image Kupper Posted - 6 days ago

$GNLX Takes real assholes to short a stock that is doing life saving research.

User Image DonCorleone77 Posted - 6 days ago

$GNLX Genelux reports Q3 EPS (19c), consensus (19c) "Over the past quarter, we marked another important step forward in our efforts to advance the systemic delivery of Olvi-Vec and to demonstrate the re-sensitization to platinum-based chemotherapy in multiple tumor types," said Thomas Zindrick, President, CEO and Chairman of Genelux. "With interim data from our SCLC trial anticipated by the end of 2024 and data releases from our Phase 3 registration trial in PRROC and Phase 2 trial in NSCLC anticipated in 2025, we are confident that Genelux is positioned to make a meaningful impact in the lives of cancer patients."

User Image Stocksrunner Posted - 6 days ago

Bouncing Back Strong! 💥Today’s rebound stars: $QBTS, $MULN $GNLX $CADL $ATAI These stocks hit their session lows but fought back to close higher—proving it’s not about how you start, but how you finish!

User Image Finanz Posted - 1 week ago

$GNLX https://www.reddit.com/r/pennystocks/comments/1gr7n88/gnlx_10_price_target_by_roth_mkm/

User Image MikeProZ Posted - 1 week ago

$GNLX https://www.tipranks.com/news/article/these-2-strong-buy-penny-stocks-are-set-to-triple-or-more-say-analysts

User Image Qukolilagani Posted - 1 week ago

$GNLX $RGC $BOLT.CN 🚀huge PR incoming, loading up. 🚨 Stock alert shared across 3 Discord groups. The 2-for-1 split is complete. Trader interest is rising, with average volume up from 28k to 81k, and recent spikes hitting 259k - 800k. Something big is brewing!

User Image MikeProZ Posted - 1 week ago

$GNLX Let's goooo

User Image MikeProZ Posted - 1 week ago

$GNLX Nice move

User Image TipRanks Posted - 1 week ago

These 2 “Strong Buy” Penny Stocks Are Set to Triple (or more), Say Analysts https://tipranks.com/news/article/these-2-strong-buy-penny-stocks-are-set-to-triple-or-more-say-analysts $GNLX $SABS -

User Image MikeProZ Posted - 1 week ago

$GNLX trending to bounce?

User Image MikeProZ Posted - 1 week ago

$GNLX https://genelux.com/about/

User Image BaronXXII Posted - 1 week ago

$RVVTF RFK knows about psychedelics. Anything with psilocybin or ketamine should hit prime time. Watch for Big Pharma to try to take out little guys (micro caps) so they can quash the IP... $PFE $MRNA $PHRRF $GNLX

User Image MikeProZ Posted - 1 week ago

$GNLX loading..

User Image JDT72 Posted - 1 week ago

$GNLX I haven't seen this posted here but Highbridge Capital Management, owned by JPMC, just released their 13G. It looks like they purchased 2.5M shares on 10/25 and they now own 6.8% of the company. Seems like good news to me, not invested but just looking through their 13G and thought I would let you know.

User Image MikeProZ Posted - 2 weeks ago

$GNLX News Out - Genelux Corporation to Participate in Fireside Chat at the Guggenheim Inaugural Healthcare Innovation Conference https://finance.yahoo.com/news/genelux-corporation-participate-fireside-chat-210100416.html?soc_src=social-sh&soc_trk=tw&tsrc=twtr

User Image MikeProZ Posted - 2 weeks ago

$GNLX Loading

User Image ANTHONYMOMO Posted - 2 weeks ago

$ELAB $0.10 coming : insane volume 42M . 72.98% of Shares Held by All Insider. 22.54% of Float Held by Institutions. bangggg like $BNOX $FOXO and $GNLX

User Image MikeProZ Posted - 2 weeks ago

$GNLX

User Image MikeProZ Posted - 2 weeks ago

$GNLX

User Image Kupper Posted - 10/31/24

$GNLX More good news and down it goes.

User Image MikeProZ Posted - 10/31/24

$GNLX News! https://finance.yahoo.com/news/individual-investors-hold-56-genelux-113716638.html

User Image MikeProZ Posted - 10/30/24

$GNLX Highbridge Capital Management LLC Acquires Significant Stake in Genelux Corp https://finance.yahoo.com/news/highbridge-capital-management-llc-acquires-170137957.html

User Image OggInvest Posted - 10/29/24

$GNLX Does anyone have the Guggenheim report to share that supports this $8 price target? Seems odd it was issued today considering they were lead underwriter for the $27M capital raise all the way back in May.

User Image BobBuran Posted - 10/29/24

Tuesday Dow opens -158 and we open carrying +$12,541 with $GNLX $LTBR $TIL and $OKLO #stocks

Analyst Ratings
Roth MKM Buy Aug 27, 24
HC Wainwright & Co. Buy Aug 15, 24
Benchmark Speculative Buy Jun 3, 24
Benchmark Speculative Buy May 31, 24
HC Wainwright & Co. Buy May 13, 24
Benchmark Speculative Buy Apr 3, 24
HC Wainwright & Co. Buy Apr 2, 24
HC Wainwright & Co. Buy Nov 27, 23
Benchmark Speculative Buy Nov 24, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Tyree James L Director Director Dec 13 Sell 13.32 9,000 119,880 3,460 12/14/23
Thomas John Director Director Dec 13 Sell 13.58 9,000 122,220 463,460 12/14/23
Yu Yong VP, Clinical Trial O.. VP, Clinical Trial Operations Dec 07 Sell 11.8477 36,800 435,995 32,535 12/08/23
Szalay Aladar 10% Owner 10% Owner Oct 25 Sell 19.3965 5,704 110,638 1,371,545 10/26/23
Szalay Aladar 10% Owner 10% Owner Oct 23 Sell 19.9725 49,987 998,365 1,377,249 10/25/23
Yu Yong VP, Clinical Trial O.. VP, Clinical Trial Operations Oct 24 Sell 19.11 5,200 99,372 106,135 10/25/23
Yu Yong VP, Clinical Trial O.. VP, Clinical Trial Operations Oct 24 Option 6 5,200 31,200 111,335 10/25/23
Thomas John Director Director Oct 16 Sell 20.9 3,333 69,660 472,460 10/16/23
Szalay Aladar 10% Owner 10% Owner Oct 05 Sell 25.18 14,251 358,840 1,427,236 10/10/23
Szalay Aladar 10% Owner 10% Owner Oct 03 Sell 25.4885 75,690 1,929,225 1,441,487 10/04/23
Szalay Aladar 10% Owner 10% Owner Sep 27 Sell 24.3 13,546 329,168 1,517,177 09/29/23
Szalay Aladar 10% Owner 10% Owner Sep 25 Sell 25.14 42,263 1,062,492 1,530,723 09/27/23
Szalay Aladar 10% Owner 10% Owner Sep 21 Sell 27.84 16,591 461,893 1,572,986 09/25/23
Szalay Aladar 10% Owner 10% Owner Sep 18 Sell 25.19 62,459 1,573,342 09/20/23
Yu Yong VP, Clinical Trial O.. VP, Clinical Trial Operations Sep 15 Sell 21.92 10,400 227,968 106,135 09/18/23
Yu Yong VP, Clinical Trial O.. VP, Clinical Trial Operations Sep 15 Option 6 10,400 62,400 116,535 09/18/23
Thomas John Director Director Sep 15 Sell 23.01 6,667 153,408 475,793 09/18/23
Yu Yong VP, Clinical Trial O.. VP, Clinical Trial Operations Sep 13 Sell 21.1385 29,800 629,927 106,135 09/15/23
Smither John W Director Director Sep 13 Sell 20.78 900 18,702 6,920 09/14/23
Szalay Aladar 10% Owner 10% Owner Sep 11 Sell 22.05 52,616 1,160,183 79,600 09/13/23
Szalay Aladar 10% Owner 10% Owner Sep 07 Sell 23.98 37,277 893,902 132,216 09/11/23
Yu Yong VP, Clinical Trial O.. VP, Clinical Trial Operations Aug 30 Sell 24.70 19,800 489,060 135,935 08/30/23
Yu Yong VP, Clinical Trial O.. VP, Clinical Trial Operations Aug 18 Sell 23.73 3,265 77,478 155,735 08/22/23
Zindrick Thomas President and CEO President and CEO Aug 18 Sell 23.73 8,349 198,122 14,651 08/22/23